While DMTs aim to modify disease progression positively, they can sometimes lead to adverse histological effects. For example, certain therapies might cause fibrosis or unintended damage to healthy tissues. Monitoring these adverse effects through regular histological assessments is crucial for ensuring patient safety and optimizing therapy.
